Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: a randomized controlled trial.
Study Goal
The researchers aimed to evaluate the effectiveness of mindfulness-based cognitive therapy (MBCT) for individuals diagnosed with cancer.
Results Summary
The study found large and significant improvements in mindfulness, depression, anxiety, and distress, as well as a trend for improved quality of life in MBCT participants compared to the wait-list group. Similar improvements were observed in the wait-list group after they received the intervention.
Population
Individuals diagnosed with cancer, across site and stage (N = 115).
Effective Dosage
8 weekly 2-hour sessions, plus daily meditation for up to 1 hour and an additional full-day session.
Duration
8 weeks (plus a 3-month post-intervention assessment for the treatment group).
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cognitive therapy (MBCT) | increase | mindfulness | individuals with a diagnosis of cancer | effect size (ES) = 0.55 | large and significant improvements | #1 |
mindfulness-based cognitive therapy (MBCT) | decrease | depression | individuals with a diagnosis of cancer | effect size (ES) = 0.83 | large and significant improvements | #2 |
mindfulness-based cognitive therapy (MBCT) | decrease | anxiety | individuals with a diagnosis of cancer | effect size (ES) = 0.59 | large and significant improvements | #3 |
mindfulness-based cognitive therapy (MBCT) | decrease | distress | individuals with a diagnosis of cancer | effect size (ES) = 0.53 | large and significant improvements | #4 |
mindfulness-based cognitive therapy (MBCT) | increase | quality of life | individuals with a diagnosis of cancer | effect size (ES) = 0.30 | trend for improvement | #5 |
OBJECTIVE: This study evaluated the effectiveness of mindfulness-based cognitive therapy (MBCT) for individuals with a diagnosis of cancer. METHOD: Participants (N = 115) diagnosed with cancer, across site and stage, were randomly allocated to either the treatment or the wait-list condition. Treatment was conducted at 1 site, by a single therapist, and involved participation in 8 weekly 2-hr sessions that focused on mindfulness. Participants meditated for up to 1 hr daily and attended an additional full-day session during the course. Participants were assessed before treatment and 10 weeks later; this second assessment occurred immediately after completion of the program for the treatment condition. The treatment condition was also assessed at 3 months postintervention. All postinitial assessments were completed by assessors who were blind to treatment allocation. RESULTS: There were large and significant improvements in mindfulness (effect size [ES] = 0.55), depression (ES = 0.83), anxiety (ES = 0.59), and distress (ES = 0.53) as well as a trend for quality of life (ES = 0.30) for MBCT participants compared to those who had not received the training. The wait-list group was assessed before and after receiving the intervention and demonstrated similar change. CONCLUSIONS: These improvements represent clinically meaningful change and provide evidence for the provision of MBCT within oncology settings.